AIM
NPTN

Aigen Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Aigen Investment Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-48
Closed – – 1666
2019
Q4 		$0 Buy
+48
New +$359 ﹤0.01% 1166

Other funds holding NPTN

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aigen Investment Management's NPTN Position: Q1 2020 in Review

Aigen Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2020, closing a stake of 48 shares.

Aigen Investment Management first reported a position in NPTN in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 135 funds tracked by Wall St. Rank hold NPTN as of Q1 2020.

  • Aigen Investment Management reported no remaining NEOPHOTONICS CORP position as of Q1 2020 after selling out during the quarter.
  • Aigen Investment Management sold 48 NEOPHOTONICS CORP shares in Q1 2020.
  • Aigen Investment Management first reported a position in NEOPHOTONICS CORP in Q4 2019 and held it in 1 quarter.
  • Aigen Investment Management's NEOPHOTONICS CORP position peaked at $0 in Q4 2019.
  • 135 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2020.

Based on Aigen Investment Management's 13F filing for Q1 2020, filed 8 May 2020.